Inhibitors
Antibodies

Primary Antibodies

Invivo Functional Antibodies

Biosimilar Antibodies
Compound Libraries
New Products
Contact Us

CX-5461 (Pidnarulex) Combination Database

Validated CX-5461 (Pidnarulex) Combination Schemes—Peer-Reviewed Data Compiled from Primary Literature.

🎯 check CX-5461 (Pidnarulex) product page

Jump to:

CX-5461 (Pidnarulex) Mechanism of Action: RNA Polymerase I Inhibition in Homologous Recombination Deficient Cancer Cells Research
CX-5461 (Pidnarulex) Working Concentration | Cell Culture | Treatment
CX-5461 (Pidnarulex) Solubility in DMSO
CX-5461 (Pidnarulex) Storage & Stability
CX-5461 (Pidnarulex) Molecular Weight | Chemical Structure | Stock Solution
CX-5461 (Pidnarulex) IC50 for Cell-based and Cell-free Assays
CX-5461 (Pidnarulex) Sigma (509265)? Try a better option.
CX-5461 (Pidnarulex) MCE (HY-13323)? Try a better option.
CX-5461 (Pidnarulex) Cayman (18392)? Try a better option.
CX-5461 (Pidnarulex) Santa Cruz (sc-507275)? Try a better option.
CX-5461 (Pidnarulex) Abmole (M2293)? Try a better option.
CX-5461 (Pidnarulex) SDS｜MSDS
CX-5461 (Pidnarulex) in Homologous Recombination Deficient (HRD) Solid Tumors
CX-5461 (Pidnarulex) in MYC-Driven Hematological Malignancies
CX-5461 (Pidnarulex) in Immuno-Oncology Combination Therapy